Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Salvage Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00002566
What this trial is testing

Combination Chemotherapy With Bone Marrow Transplantation in Treating Men With Germ Cell Tumors

Who this might be right for
Extragonadal Germ Cell TumorTesticular Germ Cell Tumor
UNICANCER 280
Testing effectiveness (Phase 2)Ended earlyNCT03352414
What this trial is testing

Phase 2 RCT of Alvimopan vs. Placebo After CRS/HIPEC

Who this might be right for
Ileus
University of California, San Diego 84
Testing effectiveness (Phase 2)Study completedNCT01711112
What this trial is testing

Salvage Docetaxel for Pretreated Urothelial Cancer

Who this might be right for
Bladder Cancer
Samsung Medical Center 31
Not applicableLooking for participantsNCT06043999
What this trial is testing

Salvage Chemotherapy Versus Total Mesorectal Resection for Local Resection Rectal Cancer Patients

Who this might be right for
Chemotherapy EffectRectal Cancer
Sun Yat-sen University 392
Early research (Phase 1)UnknownNCT02280993
What this trial is testing

Phase I/II Feasibility Study Combining Brentuximab Vedotin With Second Line Salvage Chemotherapy (DHAP) in Hodgkin Lymphoma Patients

Who this might be right for
Hodgkin LymphomaRefractoryRelapse
Marjolein Spiering 72
Not applicableUnknownNCT04500886
What this trial is testing

Evaluate the Efficacy and Safety of PEG-rhG-CSF in Patients With Hemophagocytic Syndrome

Who this might be right for
Hemophagocytic Syndrome
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07637851
What this trial is testing

Safety and Efficacy of Ubamatamab With First-line Chemotherapy in Ovarian Cancer

Who this might be right for
Ovarian Cancer
ARCAGY/ GINECO GROUP 43
Post-approval studies (Phase 4)UnknownNCT01766765
What this trial is testing

Early Jejunostomy Nutrition Minimizes Time to Chemotherapy

Who this might be right for
Gastric CancerLaparoscopic SurgeryChemotherapy
Jinling Hospital, China 100
Testing effectiveness (Phase 2)Study completedNCT01481272
What this trial is testing

Ofatumumab With IVAC Salvage Chemotherapy in Diffuse Large B Cell Lymphoma Patients

Who this might be right for
Diffuse Large B Cell Lymphoma
Polish Lymphoma Research Group 77
Large-scale testing (Phase 3)UnknownNCT02427919
What this trial is testing

Granulocyte Colony Stimulating Factor (G-CSF) After Salvage Chemotherapy in Refractory AML

Who this might be right for
Leukemia, Myeloid, Acute
Seoul St. Mary's Hospital 56
Testing effectiveness (Phase 2)Looking for participantsNCT06840834
What this trial is testing

Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and Chemotherapy

Who this might be right for
Pleural Mesotheliomas
Intergroupe Francophone de Cancerologie Thoracique 38
Testing effectiveness (Phase 2)Study completedNCT00574496
What this trial is testing

Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center 25
Testing effectiveness (Phase 2)Looking for participantsNCT07195734
What this trial is testing

Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

Who this might be right for
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Locally Recurrent Head and Neck Squamous Cell Carcinoma+15 more
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT03250338
What this trial is testing

Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AML

Who this might be right for
Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations
Arog Pharmaceuticals, Inc. 106
Not applicableLooking for participantsNCT07493876
What this trial is testing

Enhanced Recovery After Surgery (ERAS) in Patients With Peritoneal Carcinomatosis Undergoing Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Who this might be right for
Peritoneal Carcinomatosis
Fondazione del Piemonte per l'Oncologia 300
Testing effectiveness (Phase 2)UnknownNCT01535183
What this trial is testing

Irinotecan Combination Chemotherapy for Refractory or Relapsed Brain Tumor in Children and Adolescents

Who this might be right for
Brain Tumor
Seoul National University Hospital 40
Not applicableStudy completedNCT01470924
What this trial is testing

Acute Lymphoblastic Leukemia Relapse in Sweden 2003-2007

Who this might be right for
Acute Lymphoblastic Leukemia
Region Örebro County 76
Large-scale testing (Phase 3)Looking for participantsNCT06128980
What this trial is testing

Withdrawal of Treatment for Heart Failure Patients With Recovery From Tachycardia-induced Cardiomyopathy

Who this might be right for
Heart Failure With Reduced Ejection FractionHeart Rhythm Disorder
Herlev and Gentofte Hospital 348
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07757672
What this trial is testing

Salvage Chemotherapy With Sonrotoclax, Cladribine, and Standard-dose Cytarabine, Sequentially Followed by HSCT for R/R AML.

Who this might be right for
AML (Acute Myelogenous LeukemiaHSCT
Institute of Hematology & Blood Diseases Hospital, China 50
Testing effectiveness (Phase 2)UnknownNCT00551122
What this trial is testing

Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors

Who this might be right for
Brain and Central Nervous System TumorsExtragonadal Germ Cell TumorOvarian Cancer+1 more
University of Southampton 23
Next Page
180